| 2024-02-27 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,405 0.0083% | $0.73 | $2,493 | +8.77% | |
| 2023-11-28 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,720 0.0096% | $0.50 | $1,860 | +36.2% | |
| 2023-08-28 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,512 0.0093% | $1.45 | $5,092 | -50.63% | |
| 2023-05-25 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,635 0.0091% | $1.42 | $5,160 | -43.34% | |
| 2023-02-27 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,599 0.0094% | $1.68 | $6,051 | -25.75% | |
| 2022-11-28 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,532 0.0101% | $2.72 | $9,606 | -42.66% | |
| 2022-08-25 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,655 0.0091% | $4.02 | $14,679 | -59.98% | |
| 2022-05-25 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,596 0.0092% | $1.90 | $6,836 | +14.72% | |
| 2022-02-28 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,998 0.0108% | $2.78 | $11,112 | +6.23% | |
| 2021-11-29 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 4,325 0.0122% | $4.82 | $20,843 | -22.1% | |
| 2021-11-26 | Sale | Viracta Therapeutics, Inc. VIRX | CFO and COO | 3,254 0.0086% | $4.80 | $15,621 | -26.03% | |
| 2019-07-01 | Sale | Regulus Therapeutics Inc. RGLS | Chief Financial Officer | 2,669 0.0122% | $1.31 | $3,500 | -49.28% | |
| 2019-05-15 | Sale | Regulus Therapeutics Inc. RGLS | Chief Financial Officer | 10,000 0.0634% | $1.41 | $14,089 | -46.62% | |
| 2019-04-01 | Sale | Regulus Therapeutics Inc. RGLS | Chief Financial Officer | 3,253 0.0194% | $0.98 | $3,192 | -19.39% | |
| 2017-07-25 | Regulus Therapeutics Inc. RGLS | Chief Financial Officer | 54,945 0.05% | $0.91 | $50,000 | -17.12% |